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SUmmary Some laboratory findings and a few case reports support the treatment 
of chronic venous ulcers with photodynamic therapy. We treated 19 patients with 
refractory chronic venous ulcers using photodynamic therapy. The ulcers healed 
in 15 cases (78.9%) after an average of 6.8 photodynamic therapy sessions (range 
6.0-8.0). In the remaining 4 cases, the ulcers showed marked improvement after 10 
photodynamic therapy sessions. Photodynamic therapy seems to represent a good 
alternative therapeutic choice for refractory chronic venous ulcers.
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InTrodUCTIon
Chronic venous ulcers (CVU) are a defect in the 
skin with surrounding pigmentation and dermati-
tis, located in the lower leg, which has been present 
for greater than 30 days. They are characterized by 
persistent venous hypertension and abnormal ve-
nous function without a primary or associated arte-
rial, immunologic, endocrine, or systemic cause. CVU 
represent the severest and most debilitating form of 
chronic venous disease, as well as a major cause of 
working days being lost and increased health care 
costs. Evidence-based data suggest that the most 
effective treatments for CVU are compression and 
wound dressing.
Already widely used for the treatment of cutane-
ous precanceroses and superficial nonmelanoma 
skin cancer, topical photodynamic therapy (PDT) 
is emerging as an effective therapeutic option for a 
number of other dermatologic conditions, including 
inflammations (acne vulgaris, psoriasis) and infec-
tions (warts/condylomas, leishmaniasis, tineas).
There is substantial in vitro and in vivo data show-
ing that PDT is effective in treating ulcers, mainly due 
to its antibacterial properties (1). Also, some case re-
ports have recently shown that PDT may be effective 
in treating CVU (2-4).
We report on a case of CVU treated with topical 
PDT and review the literature on the topic.
maTerIalS and meThodS
Upon informed consent, subjects affected by CVU 
and recalcitrant to conventional treatments were en-
rolled in this off-label, prospective, and monocentric 
case series, carried out in Italy according to the Decla-
ration of Helsinki (6th revision, 2008). All patients had 
undergone only topical treatments (antiseptic mea-
sures and hyaluronic acid-containing dressings) for 
two months prior to entering the study. Swabs had 
revealed infection with Staphylococcus aureus and/or 
Enterococcus faecalis in all cases.
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Before starting PDT, patients were administered a 
galenic anesthetic cream (lidocaine 20% + prilocaine 
5% + tetracaine 5% in jojoba oil) (Farmacia Parati, 
Lentate sul Seveso, Monza Brianza, Italy) followed 
by delicate surgical debridement. A galenic gel con-
taining 16% 5-aminolevulinic acid (Farmacia di Santa 
Maria Nuova, Florence, Italy) was applied topically on 
Patient Sex Age N. CVU Location Swab Associated conditions N. PDT Outcome
1 F 58 2 Malleolus E. f., S. a. NIDDM 10 Improved. Healed via 
autologous graft
2 F 83 1 Medial malleolar E. f. 6 Healed
3 F 50 1 Medial malleolar E. f., S. a. NIDDM 7 Healed
4 F 78 1 Medial malleolar S. a. NIDDM 6 Healed
5 F 72 4 Lower third of the leg E. f., S. a. NIDDM 10 Improved. Healed via 
autologous graft
6 F 76 1 Medial malleolar S. a. 6 Healed
7 F 86 3 Lower third of the leg S. a. Raynaud phenomenon 8 Healed
8 F 73 1 Medial malleolar S. a. 6 Healed
9 F 79 3 Lower third of leg E. f., S. a. Raynaud phenomenon 10 Improved. Healed via 
autologous graft
10 F 53 3 Lower third of leg E. f., S. a.s 8 Healed
11 F 51 1 Medial malleolar S. a. 6 Healed
12 M 63 1 Medial malleolar S. a. 6 Healed
13 M 61 1 Medial malleolar E. f., S. a. NIDDM 6 Healed
14 M 74 1 Medial malleolar E. f., S. a. NIDDM 6 Healed
15 M 82 2 S. a. NIDDM 8 Healed
16 M 76 1 Medial malleolar E. f. 7 Healed
17 M 71 2 Malleolus E. f., S. a. NIDDM 10 Improved. Healed via 
autologous graft
18 M 60 4 Lower third of the leg S. a. 8 Healed
19 M 58 2 Malleolus E. f. NIDDM 8 Healed
Legend: N. CVU: number of chronic venous ulceration; N. PDT: number of photodynamic therapy sessions; F: 
female; M: male; NIDDM: non insulin-dependent diabetes mellitus, E. f.: Enterococcus faecalis; S. a.: Staphylocos-
sus aureus
Table 1. Main characteristics of our case series
Figure 1. a. Ulcer on the medial aspect of left ankle (patient No. 8). B. Ulcer in A has healed after six photody-
namic therapy sessions.
the ulcers and surrounding abnormal areas, and cov-
ered with a polyethylene dressing. After 3 hours, the 
application sites were irradiated perpendicularly to 
the cutaneous surface with 140 mJ/cm2/sec of con-
tinuous-mode red light with peak emission at 618 nm 
(PDT-CLD 100; E.P.E.M. s.r.l., Florence, Italy; tip diam-
eter: 5 cm), for a total dose of 100 J/cm2 (average irra-
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diation time: about 12 min). The same procedure was 
repeated every other week for up to 10 times. Dress-
ings with hyaluronic acid were applied and no other 
treatment was carried out during the study period.
reSUlTS
As detailed in Table 1, 19 patients were enrolled in 
the study (11 women, 8 men; average age 68.6 years, 
range 50-86). All patients were suffering from mod-
erate-to-severe chronic venous disease, 9 (47.4%) 
from non-insulin dependent diabetes mellitus, and 2 
(10.6%) from the Raynaud phenomenon. Ulcers were 
single in 10 cases (52.6%) and multiple in 9 (47.4%); 
the malleolar/perimalleolar area was involved in all 
instances.
Ulcers healed in 15 cases (78.9%) after an average 
of 6.8 PDT sessions (range 6.0-8.0) (Fig. 1). In the re-
maining 4 cases, ulcers improved greatly after 10 PDT 
sessions and patients were suggested to undergo an 
autologous skin graft.
No side effects were recorded beside the usual: 
well-tolerated pain during light application and mild 
erythema/edema during the following 24-48 hours.
dISCUSSIon
To our knowledge, our 19 patients with CVU treat-
ed with PDT represent the largest series reported so 
far. We showed that PDT be a safe and effective op-
tion for healing CVU which are refractory to other 
topical treatments. Such results confirm the scant 
data already present in the literature (2-4). In fact, 
combining the information from such papers (2 case 
reports (2-4) and a series of six cases (3)), five out of 
eight patients affected by recalcitrant CVU were com-
pletely healed (5 women, 3 men; average age 74.1 
years, range 60-86), two greatly improved, and one 
did not. The average number of PDT sessions was 5.7 
(range 2-8). 
The exact pathogenesis of CVU remains unknown. 
Suggested mechanisms include pericapillary fibrin 
cuffs preventing the passage of oxygen and nutrients, 
sequestering of growth factors by macromolecules 
(e.g. fibrinogen and α2-macroglobulin) leaked into 
the dermis, local ischemia and release of proteolytic 
enzymes induced by white blood cells, and the det-
rimental effects of excess tumor necrosis factor-α (as 
well as of other innate immune system-related cyto-
kines) to the process of wound healing, as observed 
within CVU (5). The loss of skin integrity provides a 
favorable environment for bacteria to colonize and 
proliferate. 
Thus, PDT may be effective in CVU treatment 
through several hypothetical mechanisms, at least in 
part suggested by in vitro and in vivo studies carried 
out in other contexts: modulation of cell-mediated 
immunity, antimicrobial activity including activity 
against biofilm-embedded bacteria, restoration of 
dermal matrix metalloproteinases, and marginal ke-
ratinocyte photoactivation.
ConClUSIon
Despite the limitations of the present and previ-
ous studies, PDT seems to represent a good thera-
peutic alternative for refractory CVU. More research 
is warranted in order to better understand the effec-
tiveness, safety profile, and cost/benefit ratio of PDT 
in CVU and wound healing in general.
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